COVID-19: Find information and support for business on our coronavirus page.
×

BioMedTech Horizons Program


The BioMedTech Horizons Program provides organisations with funding to develop medical technologies and devices through to proof of concept.

Closed

What do you get?

Funding of up to $1 million.

Who is this for?

Biomedical technology and pharmaceutical companies.

Overview

This program aims to support projects that:

  • develop new biomedical innovations and technologies in Australia to benefit Australians
  • grow our biomedtech sector by ensuring that Australia’s world-class research is translated into real treatments, drugs and devices
  • boost employment and grow businesses in Australia’s biomedtech sector

Examples of eligible expenditure include:

  • prototype development and/or validation
  • in-vivo proof-of-concept studies in relevant disease models for therapeutic opportunities
  • software coding and documentation to enable field trials or alpha/beta testing
  • external advice on IP, market, business planning
  • labour costs for contract staff employed for specific project purposes
  • direct research costs specific to the project

What are the eligibility criteria?

To be eligible, your organisation must:

  • be an Australian based small to medium enterprise, employing up to 200 staff
  • have an Australian business number (ABN)
  • be at a stage of development equivalent to Level 3 or beyond on the Technology Readiness Level Scale and have preliminary data demonstrating Technical Proof of Concept

How do you apply?

You can find out more about eligibility and how to apply at BioMedTech Horizons Program.